Summary The authors attempted to investigate the host's immune response against colorectal carcinoma through the expression of HLA-DR antigen on carcinoma cells (Ca) and on normal epithelia immediately adjacent to carcinoma (AN) in relation to tumour progression. The expression of HLA-DR antigen on Ca and on normal epithelia, both on AN and those 5 -10 cm removed from the carcinoma (RN), were examined immunohistochemically. mRNAs of cytokines, IFN-y and TNF-a, were detected by reverse transcriptionpolymerase chain reaction (RT-PCR) in both carcinoma and remote normal tissues. On the other hand, other experimental results have indicated that normal epithelia in colorectal tissues do not normally express HLA-DR antigen (Durrant et al., 1987; Matsumoto et al., 1989; Horie et al., 1990; Garrido et al., 1993; Selby et al., 1983) . Therefore, the expression of HLA-DR antigen on carcinoma cells or on normal epithelia might be induced by interferon-y (IFN-y) produced by interstitial cells, or tumour infiltrating lymphocytes (TIL) (Rognum et al., 1987; Hamilton et al., 1991) , as this cytokine reportedly induces HLA-DR antigen in a variety of cell lines (Krief et al., 1989; Lahat et al., 1993; Pober, 1988) . It is also well known that both tumour necrosis factor-a (TNF-ox) and IFNy can have either a synergistic or an antagonistic effect on the immune system (Raitano and Korc, 1990; Watanabe and Jacob, 1991) .
It is still controversial whether or not HLA antigen expression in carcinomas correlates with the development of carcinoma and prognosis (McDougall et al., 1990; Moller et al., 1991; Durrant et al., 1987) , although a number of clinical and experimental data have been published on this issue (Krief et al., 1989; Andersen et al., 1993) . The immune responses involving HLA antigens expressed on carcinoma cells are thought to play an important role in eliminating mutated cells or suppressing carcinoma progression. As reported in some recent studies, the reduced expression of HLA antigens in colorectal tissues has been proposed as a mechanism whereby carcinomas protect themselves from hosts' immunosurveillance.
On the other hand, other experimental results have indicated that normal epithelia in colorectal tissues do not normally express HLA-DR antigen (Durrant et al., 1987; Matsumoto et al., 1989; Horie et al., 1990; Garrido et al., 1993; Selby et al., 1983) . Therefore, the expression of HLA-DR antigen on carcinoma cells or on normal epithelia might be induced by interferon-y (IFN-y) produced by interstitial cells, or tumour infiltrating lymphocytes (TIL) (Rognum et al., 1987; Hamilton et al., 1991) , as this cytokine reportedly induces HLA-DR antigen in a variety of cell lines (Krief et al., 1989; Lahat et al., 1993; Pober, 1988) . It is also well known that both tumour necrosis factor-a (TNF-ox) and IFNy can have either a synergistic or an antagonistic effect on the immune system (Raitano and Korc, 1990; Watanabe and Jacob, 1991) .
In this study, the authors examined the expression of HLA-DR antigen on carcinoma cells (Ca), normal epithelia immediately adjacent to carcinoma (AN) and epithelia obtained from remote normal tissues 5 10 cm away from carcinoma (RN). At the same time, IFN-y and TNF-x mRNAs in the tissues were analysed.
We also attempted to elucidate the significance of the expressed HLA-DR antigen on carcinoma tissues by studying the relation to the local immune responses of the host and disease stages (Dukes' classification). Sets of tissue samples consisting of Ca, AN and RN were obtained from all cases. Surgically resected specimens, embedded in optimal cutting temperature compound (OCT), were frozen in liquid nitrogen and stored at -80°C until used.
Immunohistochemical procedures for HLA-DR antigen Four micron cryostat sections mounted on slides and pretreated with 5% Bioden meshcement/toluene were stained immunohistochemically by the avidin -biotin complex method (Hsu et al., 1981) . Briefly, air-dried sections were fixed in cold acetone for 20 min and washed with phosphatebuffered saline (PBS) for 5 min. After pretreatment with normal rabbit serum, the sections were incubated with primary monoclonal antibodies at appropriate dilutions in a humidified chamber for 1 h at room temperature. The monoclonal antibody used in this study was HU-20, a monomorphic anti-HLA-DR antibody (Koide et al., 1982) . After washing in PBS, the sections were incubated with biotinylated anti-mouse immunoglobulin as a second antibody for 30 min. The sections were then incubated with horseradish peroxidase-conjugated streptavidin-biotin complex for 30 min. Peroxidase activity was visualised by DAB solution (20 mg of 3,3'-diaminobenzidine, 65 mg of sodium azide, and 10 ml of 30% hydrogen peroxide in 100 ml of 0.05 M Tris buffer at pH 7.6). Haematoxylin was used for counterstaining.
Correspondence: K Matsushita, Department of Surgery, National Sakura Hospital, 2-36-2 Ebaradai, Sakura 285, Japan Received 5 June 1995; revised 22 September 1995; accepted 29 September 1995 Microscopic evaluation was carried out as follows. Stained sections were reviewed independently by at least two trained pathologists (T T and K M). Cases with more than 10% of carcinoma cells strongly stained in the membrane and/or cytoplasm with HU-20 specific for HLA-DR antigen were regarded as positive.
To test the specificity of the staining procedure, the primary antibody, HU-20, was omitted in staining an HLA-DR-positive tumour (as a negative control). To test the specificity of the primary antibody, lymphocytes of the lymph node were stained (as a positive control). For RN we took into consideration the stain intensity as well as the stained area, because in those epithelia positive staining was limited to small areas near the lymph follicles.
RT-PCR Total RNAs were extracted from colorectal tissues by the guanidinium/caesium chloride procedure (Chirgwin et al., 1979) . To detect IFN-y and TNF-a mRNAs, reverse transcription -polymerase chain reaction (RT -PCR) and consecutive Southern blot analysis were performed. A DNAase treatment was done before reverse transcription. The sequences of the primers used in this study are 5'-ATGAAATATACAAGTTATATCTTGGCTTT-3' (sense, nt 130-158) and 5'-GATGCTCTTCGACCTCGAAACAGCA T-3' (antisense, nt 598-623) for IFN-y, 5'-GTTCCTCAGC-CTCTTCTCCT-3' (sense, nt [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] and 5'-GCAGGGG-CTCTTGATGGCAG-3' (antisense, nt 597-616) for TNF-oc. The respective PCR product sizes were 494 bp and 439 bp. RT-PCR was performed with a commercially available RT-PCR kit (Amersham). After converting 2 ig of each total RNAs to cDNA, the samples were subjected to 34 amplification cycles (1 min at 94°C, 30 s at 54°C, 1.5 min at 72°C; complete cycle 8.5 min) in a PC-700 thermal cycler (Astec). Beta -actin was used as an internal control to confirm the amplification condition. The PCR reaction mixtures contained 5 ,ul of 10 x Taq polymerase buffer, 200 ,UM dNTPs, 100 pmol of primers and 2.5 units of Taq DNA polymerase in a final volume of 50 p,l.
Each 10 jul of PCR products was electrophoresed on 1.5% agarose gel and subsequently transferred onto nylon membrane filters. The membranes were hybridised with the PCR product amplified by the same primers for IFN-y and by an internal probe for TNF-ax. These probes had been labelled with [32P]a-deoxynucleoside triphosphates with a random primed DNA labelling kit (Amersham). To confirm the accuracy of PCR, each PCR product was digested with restriction enzymes, DraI for IFN-y and PvuII for TNF-ax.
Results
Immunohistochemical staining for HLA-DR antigen As shown in Table I , the proportions of HLA-DR antigenpositive cases were 27 of 49 (55.1 %) on Ca and 37 of 49 (75.5%) on AN. In comparison, the expression of HLA-DR (James et al., 1991) . Recent experimental data in vitro have demonstrated that IFN-y can induce HLA-DR antigen on several kinds of cells (Balkwill, 1989; Dinarello and Mier, 1987; Gumina et al., 1991; Tomoda et al., 1992) . In this paper we have tried to show that HLA-DR antigen expression on epithelial cells in colorectal carcinoma tissues correlates with tumour progression and IFN-y production, possibly by tumour-infiltrating lymphocytes (TILs) (Hamilton et al., 1991) .
As shown in Tables I and II (Raitano and Korc, 1990; Sugarman et al., 1985) . Secondly, the receptor for IFN-y or signal transduction pathways on these carcinoma cells might be different from those of normal epithelia (Gumina et al., 1991) . Finally, there also remains the possibility that carcinoma cells regulate their own HLA-DR antigen and modulate or escape the local immune responses.
The reason why IFN-y mRNA was scarcely detected in type (d) patients (Table III) may be related to the number or function of TIL in tissue. For example, the number of TIL decreases in advanced breast, stomach and colon carcinomas (Watt and House, 1978) . Furthermore, the 4 chain of the T cell receptor complex on TIL has been shown to decrease or vanish in some advanced carcinomas (Mizoguchi et al., 1992; Nakagomi et al., 1993) . Figure 2 shows the heterogeneous expression of HLA-DR antigen on carcinoma cells, a phenomenon also reported by other groups (Rognum et al., 1987 (Lampert et al., 1985) ? (3) Which cells express IFN-y and TNF-oe and where are they localised in relation to normal and/or tumour cells? Answers to these questions will require considerable further study.
In the present study we also used immunohistochemical staining to examine HLA-class I antigen expression using the monoclonal antibody w6/32, which recognises the common epitope of HLA-A, -B and -C antigens. There was no significant difference in the tissues observed (data not shown), although allelic loss of one or more class I molecules is reported in colorectal carcinomas (Versteeg et al., 1989 
